Focus groups on patient perspectives of precision cancer medicine

• Research type

  Research Study

• Full title

  Focus groups to determine patient preference factors and attitudes towards precision cancer medicine.

• IRAS ID

  203595

• Contact name

  Ben Fulton

• Sponsor organisation

  NHS Greater Glasgow and Clyde

• Clinicaltrials.gov Identifier

  GN16ON175, R&D reference number

• Duration of Study in the UK

  0 years, 0 months, 22 days

• Research summary

  There has been a marked increase in recent years of cancer treatments utilising precision cancer medicine, where specific treatments are tailored to an individual patient based on the unique characteristics of the patient and their cancer. This has led to an increasing complexity around decision-making for such treatments, resulting in often complex trade-offs between risks and benefits of these precision cancer medicine therapies. The aim of these focus groups are to ask patients previously diagnosed with cancer about their perspectives on precision cancer medicine and the elements they feel are important if the specialty is to meet its promise and develop more widespread approval and appeal for patients. Patients will be asked about the factors they feel are strengths of precision cancer medicine and those they may perceive as barriers to potential involvement. This will be done via 3 semi-structured focus groups in order to allow patients to openly express independent thoughts within an informal setting.

• REC name

  London - Bromley Research Ethics Committee

• REC reference

  16/LO/1665

• Date of REC Opinion

  8 Sep 2016

• REC opinion

  Favourable Opinion